• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗白内障药理学治疗的最新进展和研究趋势:文献计量分析和综述。

Recent progress and research trend of anti-cataract pharmacology therapy: A bibliometric analysis and literature review.

机构信息

Southwest Hospital/Southwest Eye Hospital, Third Military Medical University (Army Medical University), Chongqing, China; Key Lab of Visual Damage and Regeneration & Restoration of Chongqing, Chongqing, China; The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology and Chongqing Eye Institute, Chongqing, China.

Southwest Hospital/Southwest Eye Hospital, Third Military Medical University (Army Medical University), Chongqing, China; Key Lab of Visual Damage and Regeneration & Restoration of Chongqing, Chongqing, China.

出版信息

Eur J Pharmacol. 2022 Nov 5;934:175299. doi: 10.1016/j.ejphar.2022.175299. Epub 2022 Sep 29.

DOI:10.1016/j.ejphar.2022.175299
PMID:36181780
Abstract

Cataract is the leading cause of blindness worldwide. Cataract phacoemulsification combined with intraocular lens implantation causes great burden to global healthcare, especially for low- and middle-income countries. Such burden would be significantly relieved if cataracts can effectively be treated or delayed by non-surgical means. Excitingly, novel drugs have been developed to treat cataracts in recent decades. For example, oxysterols are found to be able to innovatively reverse lens clouding, novel nanotechnology-loaded drugs improve anti-cataract pharmacological effect, and traditional Chinese medicine demonstrates promising therapeutic effects against cataracts. In the present review, we performed bibliometric analysis to provide an overview perspective regarding the research status, hot topics, and academic trends in the field of anti-cataract pharmacology therapy. We further reviewed the curative effects and molecular mechanisms of anti-cataract drugs such as lanosterol, metformin, resveratrol and curcumin, and prospected the possibility of their clinical application in future.

摘要

白内障是全球致盲的主要原因。白内障超声乳化联合人工晶状体植入术给全球医疗保健带来了巨大负担,尤其是对中低收入国家而言。如果能通过非手术手段有效治疗或延缓白内障,这种负担将大大减轻。令人兴奋的是,近几十年来已经开发出了一些治疗白内障的新药。例如,发现氧化固醇能够创新性地逆转晶状体混浊,新型载药纳米技术可提高抗白内障药理作用,而中药对白内障也显示出有希望的治疗效果。在本综述中,我们进行了文献计量分析,提供了抗白内障药理学治疗领域的研究现状、热点和学术趋势的概述。我们进一步综述了羊毛甾醇、二甲双胍、白藜芦醇和姜黄素等抗白内障药物的疗效和分子机制,并展望了它们在未来临床应用的可能性。

相似文献

1
Recent progress and research trend of anti-cataract pharmacology therapy: A bibliometric analysis and literature review.抗白内障药理学治疗的最新进展和研究趋势:文献计量分析和综述。
Eur J Pharmacol. 2022 Nov 5;934:175299. doi: 10.1016/j.ejphar.2022.175299. Epub 2022 Sep 29.
2
Failure of Oxysterols Such as Lanosterol to Restore Lens Clarity from Cataracts.甾醇氧化物(如羊毛甾醇)无法使白内障晶状体恢复透明。
Sci Rep. 2019 Jun 11;9(1):8459. doi: 10.1038/s41598-019-44676-4.
3
Advances in drug therapy and delivery for cataract treatment.用于白内障治疗的药物疗法及给药方式的进展。
Curr Opin Ophthalmol. 2023 Jan 1;34(1):3-8. doi: 10.1097/ICU.0000000000000910. Epub 2022 Nov 14.
4
Lanosterol reverses protein aggregation in cataracts.羊毛甾醇可逆转白内障中的蛋白质聚集。
Nature. 2015 Jul 30;523(7562):607-11. doi: 10.1038/nature14650. Epub 2015 Jul 22.
5
Lanosterol and 25-hydroxycholesterol dissociate crystallin aggregates isolated from cataractous human lens via different mechanisms.羊毛固醇和 25-羟胆固醇通过不同的机制解离白内障人晶状体分离的晶状体聚集物。
Biochem Biophys Res Commun. 2018 Dec 2;506(4):868-873. doi: 10.1016/j.bbrc.2018.10.175. Epub 2018 Nov 2.
6
Advances in pharmacotherapy of cataracts.白内障药物治疗的进展。
Ann Transl Med. 2020 Nov;8(22):1552. doi: 10.21037/atm-20-1960.
7
Effect of lanosterol on human cataract nucleus.羊毛甾醇对人白内障晶状体核的影响。
Indian J Ophthalmol. 2015 Dec;63(12):888-90. doi: 10.4103/0301-4738.176040.
8
Anti-cataract Effect of Resveratrol in High-Glucose-Treated Streptozotocin-Induced Diabetic Rats.白藜芦醇对高糖处理的链脲佐菌素诱导的糖尿病大鼠的抗白内障作用
Biol Pharm Bull. 2018;41(10):1586-1592. doi: 10.1248/bpb.b18-00328.
9
Pharmacological approaches to restoring lens transparency: Real world applications.恢复晶状体透明度的药理学方法:实际应用
Ophthalmic Genet. 2017 May-Jun;38(3):201-205. doi: 10.1080/13816810.2016.1214971. Epub 2016 Sep 20.
10
Reactive Oxygen Species and the Aging Eye: Specific Role of Metabolically Active Mitochondria in Maintaining Lens Function and in the Initiation of the Oxidation-Induced Maturity Onset Cataract--A Novel Platform of Mitochondria-Targeted Antioxidants With Broad Therapeutic Potential for Redox Regulation and Detoxification of Oxidants in Eye Diseases.活性氧与衰老眼睛:代谢活跃的线粒体在维持晶状体功能及氧化诱导的成熟期白内障发生中的特定作用——一种具有广泛治疗潜力的线粒体靶向抗氧化剂新平台,用于眼部疾病中氧化还原调节和氧化剂解毒。
Am J Ther. 2016 Jan-Feb;23(1):e98-117. doi: 10.1097/MJT.0b013e3181ea31ff.

引用本文的文献

1
Cataract-Causing Mutant R188C of βB2 Crystallin With Low Structural Stability is Sensitive to Environmental Stresses and Prone to Aggregates Formation.具有低结构稳定性的βB2晶状体蛋白致白内障突变体R188C对环境应激敏感且易于形成聚集体。
Exploration (Beijing). 2025 Apr 1;5(3):20240192. doi: 10.1002/EXP.20240192. eCollection 2025 Jun.
2
Compact and aberration effects-shielded objective intraocular scatter measurement system.紧凑型像差效应屏蔽式客观眼内散射测量系统。
Biomed Opt Express. 2025 Jan 27;16(2):669-678. doi: 10.1364/BOE.545245. eCollection 2025 Feb 1.
3
Oxidative Stress and Cataract Formation: Evaluating the Efficacy of Antioxidant Therapies.
氧化应激与白内障形成:评估抗氧化疗法的疗效。
Biomolecules. 2024 Aug 25;14(9):1055. doi: 10.3390/biom14091055.
4
Therapeutic Applications of Oxysterols and Derivatives in Age-Related Diseases, Infectious and Inflammatory Diseases, and Cancers.氧化固醇及其衍生物在与年龄相关的疾病、感染和炎症性疾病以及癌症中的治疗应用。
Adv Exp Med Biol. 2024;1440:379-400. doi: 10.1007/978-3-031-43883-7_19.
5
Impact of Oxysterols in Age-Related Disorders and Strategies to Alleviate Adverse Effects.氧化甾醇在与年龄相关疾病中的影响及减轻不良反应的策略。
Adv Exp Med Biol. 2024;1440:163-191. doi: 10.1007/978-3-031-43883-7_9.
6
Time trends and gender disparities of Chinese cataract burden and their predictions.中国白内障负担的时间趋势和性别差异及其预测
Int J Ophthalmol. 2023 Sep 18;16(9):1527-1534. doi: 10.18240/ijo.2023.09.21. eCollection 2023.
7
Bibliometric analysis of the Vogt‒Koyanagi‒Harada disease literature.Vogt‒Koyanagi‒Harada 病文献的计量学分析。
Int Ophthalmol. 2023 Nov;43(11):4137-4150. doi: 10.1007/s10792-023-02815-x. Epub 2023 Aug 8.
8
An Overview towards Zebrafish Larvae as a Model for Ocular Diseases.斑马鱼幼鱼作为眼部疾病模型的概述。
Int J Mol Sci. 2023 Mar 11;24(6):5387. doi: 10.3390/ijms24065387.